Filtra per Last updated date SelectDopoPrimaFrom - To Date Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Esito (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA Management Board: highlights of June 2023 meeting 9 Giugno 2023NewsCorporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5 - 8 June 2023 9 Giugno 2023NewsHumanPharmacovigilanceReferrals EMA and ECDC statement on updating COVID-19 vaccines to target new SARS-CoV-2 virus variants 7 Giugno 2023NewsHumanCOVID-19Vaccines Progress with EU-US mutual recognition agreement for inspections for veterinary medicines 31 Maggio 2023NewsHumanVeterinaryCorporateCompliance and inspections Global regulators agree on way forward to adapt COVID-19 vaccines to emerging variants 30 Maggio 2023NewsHumanCOVID-19Vaccines EMA business hours over Whit Monday, 29 May 26 Maggio 2023NewsHumanCorporate Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 May 2023 26 Maggio 2023NewsHumanMedicines Revocation of authorisation for sickle cell disease medicine Adakveo 26 Maggio 2023NewsHumanPharmacovigilance Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24 - 26 April 2023 26 Maggio 2023NewsHumanCOVID-19MedicinesVaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 12 May 2023 22 Maggio 2023NewsHumanPharmacovigilanceReferrals 1 … 29 30 31 32 33 Page 33 of 383 34 35 36 37 … 383
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5 - 8 June 2023 9 Giugno 2023NewsHumanPharmacovigilanceReferrals
EMA and ECDC statement on updating COVID-19 vaccines to target new SARS-CoV-2 virus variants 7 Giugno 2023NewsHumanCOVID-19Vaccines
Progress with EU-US mutual recognition agreement for inspections for veterinary medicines 31 Maggio 2023NewsHumanVeterinaryCorporateCompliance and inspections
Global regulators agree on way forward to adapt COVID-19 vaccines to emerging variants 30 Maggio 2023NewsHumanCOVID-19Vaccines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 May 2023 26 Maggio 2023NewsHumanMedicines
Revocation of authorisation for sickle cell disease medicine Adakveo 26 Maggio 2023NewsHumanPharmacovigilance
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24 - 26 April 2023 26 Maggio 2023NewsHumanCOVID-19MedicinesVaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 12 May 2023 22 Maggio 2023NewsHumanPharmacovigilanceReferrals